Nonsolid Nodules Unlikely to Cause Death in Lung Cancer

This article originally appeared here.
Share this content:
Nonsolid Nodules Unlikely to Cause Death in Lung Cancer
Nonsolid Nodules Unlikely to Cause Death in Lung Cancer

THURSDAY, July 7, 2016 (HealthDay News) -- In patients with lung cancer as the cause of death (COD), nonsolid nodules (NSNs) identified on computed tomography scans (CTs) tend to have an indolent course, according to a study published online July 5 in Radiology.

Rowena Yip, M.P.H., from the Icahn School of Medicine at Mount Sinai Medical Center in New York City, and colleagues used data from the National Lung Screening Trial database for 48 patients with one or more NSNs and lung cancer as the COD. Of these, 21 participants had no NSN in the cancerous lobe. CT scans of the remaining 27 patients were reviewed by four radiologists: Group A (12 patients) was composed of cases of lung cancer as the COD due to adenocarcinoma, while group B (15 patients) was composed of cases of lung cancer as the COD due to other cell types.

The researchers found that six of the patients in group A had no NSN in the cancerous lobe. The other six had a dominant solid or part-solid nodule; this rapidly grew in four patients and was multifocal in one patient. One patient, in whom diagnosis was delayed, had a growing NSN. In group B, five patients had no NSN, and for the remaining 10 patients, lung cancer as the COD was not related to the NSN.

"It seems unlikely that patients with lung cancer as the COD occurred with solitary or dominant NSN as long as annual follow-up was performed," the authors write. "This lends further support that lung cancers that manifest as NSNs have an indolent course and can be managed with annual follow-up."

One author disclosed ties to the technology industry, and two authors hold patents related to the evaluation of diseases in the chest or pulmonary nodules on CT scans.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »